The EuCARE clinical cohorts have enrolled overall more than 44.000 patients
The clinical cohorts studies have been set up to evaluate the association between circulating SARS-CoV-2 variants and the risk of developing short, mid and long-term clinical outcomes.
The EuCARE partners, until now, enrolled a total of 44,260 patients and Health Care Workers.
The three cohorts part of the clinical studies are the hospitalised patients with COVID-19 (Hospitalised) cohort, the long-term sequelae of COVID-19 symptoms after the acute infection (Post-COVID) cohort and the Health Care Workers (HCW) cohort.
To know more go to: https://eucareresearch.eu/activities/clinical-cohorts/
The EuCARE laboratory network performs the required virological and immunological assays to answer the key questions on SARS-CoV-2 variants, including the issues of escape from vaccination or natural immunization with another variant and that of detectability by specific diagnostic systems.
Overall 7783 samples have been collected and are available for these studies in EuCARE.
To know more go to: https://eucareresearch.eu/activities/laboratory-network/
In the EuCARE school study, almost 2,000 students and teachers were enrolled and included in the project.
To know more go to: https://eucareresearch.eu/activities/school-studies/